全球精準醫療市場按應用、技術和地區分類

2025 年全球精準醫療市場規模預估為 1,029.3 億美元，預計到 2032 年將達到 2,206.8 億美元，2025 年至 2032 年的複合年成長率為 11.5%。

數字。 2025 年精準醫療市場佔有率（%），依地區分類

精準醫療是一種考慮到基因、環境和生活方式的個體差異的疾病治療和預防新方法。這種方法將使醫生和研究人員能夠更準確地預測哪些針對特定疾病的治療和預防策略適用於哪些群體。這與「一刀切」的方法相反，在「一刀切」的方法中，對每個人的疾病都採用標準方式治療。精準醫療整合遺傳訊息和分子診斷，根據每位患者的個人特徵制定治療方案。了解更多有關患者的基因組成可以幫助醫生確定某些藥物、生活方式的改變或治療是否有效，或者是否應該針對每個人考慮不同的選擇。這使得研究人員和醫療保健提供者能夠確定每位患者最安全的治療方法，從而改善治療效果。隨著不斷的研究和開發，精準醫療有望透過有針對性的疾病預防和治療來改變醫療保健。

市場動態：

全球精準醫療市場受到個人化醫療需求不斷成長、精準治療藥物研發投入增加、次世代定序儀（NGS）在精準醫療中的應用不斷擴大、以及醫療儲蓄需求激增的驅動。然而，缺乏資料解釋和標準化以及治療成本的上升預計會抑制市場的成長。另一方面，新興國家為市場公司提供了高成長機會。與傳統治療方法相比，精準醫療方法可以透過提供具有更高療效和更少副作用的標靶治療來幫助解決多項快速成長的醫療挑戰。伴同性診斷的日益採用以及精準醫療納入藥物開發活動也帶來了新的機會。

本研究的主要特點

• 本報告對全球精準醫療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
• 全球精準醫療市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球精準醫療市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過用於分析全球精準醫療市場的各種策略矩陣來促進其決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 限制因素
• 市場機會
• 影響分析
• 市場趨勢
• 收購和合作場景
• 持續發展
• 波特的分析
• PEST分析

第4章 全球精準醫療市場：COVID-19 疫情的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

第 5 章。全球精準醫療市場依技術分類（2020-2032 年）

• 生物資訊學
• 基因序列分析
• 藥物研發
• 精準分子診斷
• 巨量資料分析

第6章 全球精準醫療市場依應用分類（2020 年至 2032 年）

• 腫瘤學
• 中樞神經系統
• 血液學
• 免疫學
• 呼吸系統
• 其他

第7章 全球精準醫療市場依地區分類（2020-2032）

• 各地區市場佔有率分析：2025 年及 2032 年（%）
• 各地區較去年與前一年同期比較成長分析
• 區域趨勢
• 北美洲
  • 市場規模及各技術預測、年成長與前一年同期比較
  • 市場規模及應用預測、年成長與前一年同期比較
  • 各國市場規模及預測、年成長與前一年同期比較
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 北非
  • 中部非洲
  • 南非

第8章 競爭格局

• Intomics
• GENinCode
• NanoString
• Tepnel Pharma Services Limited
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc
• QIAGEN
• Quest Diagnostics Incorporated
• Medtronic
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• bioMerieux SA
• F. Hoffmann-La Roche Ltd
• Eli Lilly & Company
• GlaxoSmithKline plc
• Cepheid
• AstraZeneca PLC
• Myriad Genetics, Inc.
• Bristol-Myers Squibb Company

第 9 章分析師觀點

• 命運之輪
• 分析師觀點
• Coherent Opportunity Map（COM）

第10章參考文獻與調查方法

• 參考
• 調查方法

Global Precision Medicine Market is estimated to be valued at USD 102.93 Bn in 2025 and is expected to reach USD 220.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

Figure. Precision Medicine Market Share (%), By Region 2025

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a ""one-size-fits-all"" approach, where disease treatment is a standardized approach for all people. Precision medicine integrates genetic information and molecular diagnostics to tailor medical treatments based on the individual characteristics of each patient. With greater knowledge of patients' genetic makeup, doctors can determine if certain medicines, lifestyle changes, or treatments will help or if different options may need to be considered depending on the individual. This allows researchers and healthcare providers to determine the safest treatment option tailored for each patient, leading to improved treatment outcomes. With continued research and development, precision medicine holds promise to transform healthcare through targeted disease prevention and treatment.

Market Dynamics:

The global precision medicine market is driven by the increasing demand for personalized healthcare, rise in R&D investments for precision therapeutics development, growing application of next-generation sequencing (NGS) in precision medicine, and surging demand for healthcare reduction. However, the lack of data interpretation & standardization and high cost of treatment are expected to restrain the market growth. Meanwhile, emerging economies offer high-growth opportunities for market players. Precision medicine approaches could help address several burgeoning healthcare challenges by offering targeted therapeutics with improved efficacy and reduced side-effects compared to conventional treatment methods. The growing adoption of companion diagnostics and inclusion of precision medicine in drug development activities also presents new opportunities.

Key Features of the Study:

• This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global precision medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMerieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market.

Market Segmentation

• Technology:
  • Bioinformatics
  • Gene Sequencing
  • Precision Molecular Diagnostics
  • Big Data Analytics
  • Others
• Application:
  • Oncology
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
  • Central Nervous System
  • Hematology
  • Immunology
  • Respiratory
  • Others
• End User:
  • Biopharmaceutical Companies
  • Diagnostic Laboratories
  • Academic & Research Institutions
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Intomics
  • GENinCode
  • NanoString
  • Tepnel Pharma Services Limited
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co. Inc
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Medtronic
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Eli Lilly & Company
  • GlaxoSmithKline plc
  • Cepheid
  • AstraZeneca PLC
  • Myriad Genetics Inc.
  • Bristol-Myers Squibb Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Acquisitions and Partnerships Scenario
• Ongoing Developments
• Porter's Analysis
• PEST Analysis

4. Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Precision Medicine Market, By Technology, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Bioinformatics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Gene Sequencing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Drug Discovery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Precision Molecular Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Big Data Analytics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Precision Medicine Market, By Application, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
• Central Nervous System
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hematology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Immunology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Respiratory
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Precision Medicine Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
• Market Share Analysis, By Region, 2025 and 2032 (%)
• Y-o-Y Growth Analysis, For Regions, 2020-2032
• Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Intomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GENinCode
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NanoString
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Tepnel Pharma Services Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc
• QIAGEN
• Quest Diagnostics Incorporated
• Medtronic
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• bioMerieux SA
• F. Hoffmann-La Roche Ltd
• Eli Lilly & Company
• GlaxoSmithKline plc
• Cepheid
• AstraZeneca PLC
• Myriad Genetics, Inc.
• Bristol-Myers Squibb Company

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact